Table 1.
Clinical laboratory data
| Laboratory data | Reference range | Baseline Feb 15 | Re-examination Feb 25 | Recurrence Mar 5 | Follow-up Mar 23 | Follow-up Apr 11 |
|---|---|---|---|---|---|---|
| WBC (× 109/L) | 3.5–9.5 | 3.11 | 4.81 | 4.99 | 4.76 | 4.57 |
| NEUT (× 109/L) | 1.8–6.3 | 2.08 | 3.01 | 3.26 | 3.01 | 2.72 |
| NEUT (%) | 40–75 | 66.90 | 62.6 | 65.4 | 63.2 | 59.4 |
| LYM (× 109/L) | 1.1–3.2 | 0.73 | 1.29 | 1.16 | 1.18 | 1.36 |
| LYM (%) | 20–50 | 23.5 | 26.8 | 23.2 | 24.8 | 29.8 |
| MONO (× 109/L) | 0.1–0.6 | 0.29 | 0.47 | 0.51 | 0.5 | 0.42 |
| MONO (%) | 3–10 | 9.3 | 9.8 | 10.2 | 10.5 | 9.2 |
| PLT (× 109/L) | 125–350 | 156 | 335 | 127 | 134 | 308 |
| Hemoglobin (g/L) | 115–150 | 96 | 81 | 83 | 84 | 99 |
| Urine protein | negative | negative | negative | negative | negative | negative |
| Urine gravity | 1.003–1.030 | 1.013 | 1.016 | 1.015 | 1.020 | 1.017 |
| pO2 (mmHg) | 83–108 | 34.0 | 101 | – | – | – |
| sO2 (%) | 92–98 | 58.9 | 98 | – | – | – |
| pCO2 (mmHg) | 35–45 | 36.4 | 34.2 | – | – | – |
| K+ (mmol/L) | 3.4–4.5 | 3.4 | 3.5 | 3.7 | 4.09 | 3.39 |
| Na+ (mmol/L) | 136–146 | 143 | 144 | 145 | 142 | 140 |
| Cl (mmol/L) | 98–106 | 111 | 111 | 109 | 108 | 108 |
| Ca (mmol/L) | 2.11–2.52 | 2.09 | 2.02 | 2.11 | 2.15 | 2.12 |
| D-dimer (mg/L) | < 1000 | 910 | ||||
| ALT (U/L) | 7–40 | 9.1 | 13.5 | 12.1 | 11 | 11.1 |
| AST(U/L) | 13–35 | 12.5 | 12 | 11.8 | 12.2 | 13.6 |
| Albumin (g/L) | 40–55 | 38.3 | 33.7 | 36.7 | 40.5 | 45.8 |
| Creatinine (μmol/L) | 41–81 | 47.7 | 42.6 | 48.8 | 51.1 | 50.0 |
| Urea nitrogen (mmol/L) | 2.6–8.8 | 2.5 | 2.17 | 3.04 | 2.96 | 3.03 |
| eGFR (mL/min/1.73 m2) | > 90 | 164.7 | 188.7 | 161.3 | 151.7 | 154 |
| TNI (μg/L) | < 0.03 | 0.001 | 0.007 | – | – | – |
| Myoglobin (μg/L) | 14.3–65.8 | 13.9 | 11 | – | – | – |
| CK-MB (U/L) | 0.6–6.3 | 0.5 | 0.8 | – | – | 5.0 |
| hs-CRP (mg/L) | 7.36 | < 0.5 | < 0.5 | < 0.5 | 0.0 | |
| CRP (mg/L) | < 10 | < 10 | < 10 | < 10 | < 10 | < 10 |
| PCT (ng/mL) | < 0.05 | > 0.05 | > 0.05 | |||
| CD45+ (cells/μL) | 1488–4483 | 1144 | 1250 | – | – | 1329 |
| CD3+CD45+ (cells/μL) | 955–2860 | 999 | 1129 | – | – | 1218 |
| CD3+CD45+ (%) | 50–84 | 87 | 90 | – | – | 92 |
| CD3+CD4+ (cells/μL) | 550–1440 | 385 | 424 | – | – | 425 |
| CD3+CD4+ (%) | 26–61 | 34 | 34 | – | – | 32 |
| CD3+CD8+ (cells/μL) | 320–1250 | 592 | 680 | – | – | 774 |
| CD3+CD8+ (%) | 15–44 | 52 | 54 | – | – | 58 |
| CD3+CD4+CD8+ (cells/μL) | 7 | 8 | – | – | 14 | |
| CD3+CD4+CD8+/CD45+ (%) | 1 | 1 | – | – | 1 | |
| CD4+/CD8+ (%) | 1.2–2.0 | 0.65 | 0.62 | – | – | 0.55 |
| IL-2 | 0–5.71 | – | 2.17 | – | – | – |
| IL-4 | 0–2.80 | – | 1.61 | – | – | – |
| IL-6 | 0–5.30 | – | 2.48 | – | – | 2.49 |
| IL-10 | 0–4.91 | – | 1.76 | – | – | – |
| TNF-α | 0–2.31 | – | 1.24 | – | – | – |
| IFN-γ | 0–7.42 | – | 0.27 | – | – | – |
Note: Values in italics were either above normal or below normal
WBC white blood cell, NEUT neutrophil, LYM lymphocyte, MONO monocyte, PLT platelet, ALT alanine aminotransferase, AST aspartate aminotransferase, eGFR estimated glomerular filtration rate, TNI troponin I, CK-MB creatine kinase-MB, CRP C-reactive protein, PCT procalcitonin, IL interleukin, TNF tumor necrosis factor, IFN-γ interferon-γ